<link href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta2/dist/css/bootstrap.min.css" rel="stylesheet" integrity="sha384-BmbxuPwQa2lc/FVzBcNJ7UAyJxM6wuqIj61tLrc4wSX0szH/Ev+nYRRuWlolflfl" crossorigin="anonymous">

<link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css" integrity="sha384-wvfXpqpZZVQGK6TAh5PVlGOfQNHSoD2xbE+QkPxCAFlNEevoEH3Sl0sibVcOQVnN" crossorigin="anonymous">

 <div class="container marketing">
      <div class="row featurette">
          <div class="col-md-7">
            <p>We are going to design and produce stable, active and targeted receptor-based drugs to combat various infectious diseases such as COVID-19.</p>
<p>Viruses use receptor proteins to enter host cells. Solubilized decoy receptors have already  been used to bind viruses extracellularly to block cell entry. However, as viruses have many surface proteins, these monomeric decoy receptors need to be used in high concentrations. Our idea is to use a sophisticated multimerization system called “SunTag” to create a chain of decoy receptors. We aim to cover the whole surface of the virus with these particles and block the cell entry much more efficiently.</p>

<p>We want to expand our preliminary results on the SARS-CoV-2 to other viruses and diseases. Simply, after identifying the receptors that disease-causing viruses use for cell entry, our aim is to prepare a SunTag-fused receptor library. Then, we will characterize all the library elements in terms of their viral neutralization efficiency. Finally, we will determine potential drugs to be used in clinical trials for these diseases. </p>
          </div>
          <div class="col-md-5">
            <img class="featurette-image img-fluid mx-auto" src="scheme.png">
          </div>
        </div>
      </div>  
      
  
        
### Check out our BioRxiv preprint

<div class="container marketing">
      <div class="row featurette">
          <div class="col-md-7">
            <p class="lead"><a href="https://www.biorxiv.org/content/10.1101/2021.01.04.425128v1" target="_blank">https://www.biorxiv.org/content/10.1101/2021.01.04.425128v1</a></p>
          </div>
          <div class="col-md-5">
           <a href="https://www.biorxiv.org/content/10.1101/2021.01.04.425128v1" target="_blank"><img class="featurette-image img-fluid mx-auto" src="ss.png"></a>
          </div>
        </div>
      </div>
      


### Inventors
 <div class="container marketing">
        <div class="row">
          <div class="col-lg-4">
            <img class="rounded-circle" src="alisan.png" width="140" height="140">
            <h2>Alişan Kayabölen, PhD</h2>
            <p>Post-doctoral Fellow in Molecular Biology</p>
            <a href="https://twitter.com/alisankayabolen" target="_blank">
    <i class="fa fa-twitter"></i>
  </a>
          </div><!-- /.col-lg-4 -->
          <div class="col-lg-4">
            <img class="rounded-circle" src="ugur.png" width="140" height="140">
            <h2>Uğur      Akcan</h2>
            <p>PhD Candidate in Neuroscience</p>
               <a href="https://twitter.com/occludens" target="_blank">
    <i class="fa fa-twitter"></i>
  </a>
          </div><!-- /.col-lg-4 -->   
          <div class="col-lg-4">
            <img class="rounded-circle" src="https://lacklab.ku.edu.tr/images/dogancan_s.jpg" width="140" height="140">
            <h2>Doğancan Özturan</h2>
            <p>PhD Candidate in Biomedical Sciences</p>  
               <a href="https://twitter.com/dogancan" target="_blank">
    <i class="fa fa-twitter"></i>
  </a>
          </div><!-- /.col-lg-4 -->
        </div>
      </div>


